MARKET

NEXI

NEXI

Neximmune, Inc.
NASDAQ
0.4090
-0.0108
-2.57%
After Hours: 0.4010 -0.008 -1.96% 16:36 02/07 EST
OPEN
0.4350
PREV CLOSE
0.4198
HIGH
0.4350
LOW
0.4060
VOLUME
71.61K
TURNOVER
0
52 WEEK HIGH
4.910
52 WEEK LOW
0.1947
MARKET CAP
10.67M
P/E (TTM)
-0.1551
1D
5D
1M
3M
1Y
5Y
Why Is NexImmune (NEXI) Stock Down 4% Today?
Investor Place · 01/20 14:04
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 01/20 13:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12/28/2022 13:06
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 12/26/2022 21:32
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 12/23/2022 21:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 11/22/2022 13:08
Sol Barer Is The Independent Chairman of the Board of NexImmune, Inc. (NASDAQ:NEXI) And They Just Picked Up 5.7% More Shares
Even if it's not a huge purchase, we think it was good to see that Sol Barer, the Independent Chairman of the Board of...
Simply Wall St. · 11/21/2022 10:05
Analyst Downgrades NexImmune After Going Back To Preclinical Stage
Benzinga · 11/16/2022 18:59
More
About NEXI
NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML) and NEXI-002 in multiple myeloma (MM). The Company provides Artificial Immune Modulation (AIM), which is a nanoparticle technology platform. Its AIM technology enables it to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. The AIM nanoparticles employ signaling proteins to deliver instructions to T cells directing a desired immune response. Its T cell product candidates are designed to combine the attributes of cellular with reduced potential for toxicities. It is also developing new AIM nanoparticle constructs and modalities for clinical evaluation in oncology and in disease areas outside of oncology.

Webull offers kinds of Neximmune Inc stock information, including NASDAQ:NEXI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEXI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NEXI stock methods without spending real money on the virtual paper trading platform.